Case Study

Personalized HCP Engagement Boosts Prescriptions for At-Risk Patients

Client

At Risk Patients

Key Results

1,753 HCPs Reached

The challenge

Challenge

A pharmaceutical company aimed to support earlier intervention with one of its treatments by identifying and engaging healthcare professionals (HCPs) treating patients showing early signs of a progressive condition. But in a crowded immunology space, where treatment delays are common, they needed a way to stand out with precise.

2,929 Additional Prescriptions Generated

The solution

Precise Targeting

Identifying patients likely to experience early symptoms of the progressive condition.

Predictive AI

Prioritizing HCPs treating these patients based on prescribing history and progression likelihood.

Channel Mix

Delivering treatment education in-EHR and across digital channels during active clinical decision-making.

The results

Results

The campaign drove measurable commercial impact in the autoimmune space. It generated a 12.2% new prescription (NRx) lift among exposed HCPs, led to 2,929 additional total prescriptions (TRx), and engaged 82 new-to-brand prescribers.

Key results

HCPs Reached

1,753

Among Exposed HCPs Total Incremental TRx

12.20%

Additional Prescriptions Generated

2,929

New-to-brand Prescribers Engaged

Results that speak for themselves.

From rare disease to mass markets, our clients move faster, waste less, and turn coordinated marketing into measurable script lift.

Data Driven Decision-Making Drove 10:1 Return on TV Ad Spend

Learn how data-driven decision making in pharma delivered a 10:1 ROI on TV ad spend through precise targeting and omnichannel engagement.

The ad ranked in the top 25% for impressions per new prescriptions (NRx) generated.

25%

Return on Advertising Spend (ROAS) Digital Display

10:1

Audience segments ranked in the top one-third for impressions per NRx generated.

3/4

AI-Powered EHR Messaging Drives Significant Referrals for Rare Disease Treatment Referral

Discover how AI in HCP engagement improved rare disease referrals by delivering timely, EHR-based education to pediatricians and specialists.

Higher Overall Referral Rate in the test group compared to the control group.

23x

Increase in Pediatric Endocrinology Referrals in the test group versus the control group.

110x

Increase in Pediatric Genetics Referrals in the test group

~6x

Improving Audience Quality for CTV with Clinical Connected Datasets

See how OptimizeRx drove ROI in pharma CTV advertising by using clinical data and Micro-Neighborhood® targeting to improve audience quality.

OptimizeRx targeting had the best performance of all partners in both audience quality and cost per diagnosed patient

Our Micro-Neighborhood® targeting platform produced higher audience quality than the national benchmark

Higher audience quality rate than the next performing partner

60%

Healthcare marketing is evolving.

Ready for more than just a data vendor?